 |
市場調査レポート
商品コード
1373769
脳性麻痺治療の世界市場 - 市場規模、シェア、成長分析：タイプ別（手術、投薬）、流通別（病院薬局、小売薬局、オンライン薬局） - 業界予測（2023年～2030年）Global Cerebral Palsy Treatment Market Size, Share, Growth Analysis, By Type(Surgery and Medication), By Distribution(Hospital pharmacies, Retail pharmacies and Online pharmacies) - Industry Forecast 2023-2030 |
||||||
| 脳性麻痺治療の世界市場 - 市場規模、シェア、成長分析：タイプ別（手術、投薬）、流通別（病院薬局、小売薬局、オンライン薬局） - 業界予測（2023年～2030年） |
|
出版日: 2023年10月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の脳性麻痺治療の市場規模は2021年に31億1,000万米ドル、2022年に32億1,000万米ドルとなりました。同市場は、予測期間中（2023年～2030年）に3.3%のCAGRで拡大し、2030年には43億米ドルに達する見通しです。
世界の脳性麻痺治療市場は、ヘルスケア産業においてダイナミックかつ急速に成長している分野です。脳性麻痺は、筋肉の制御、協調性、運動に影響を及ぼす神経疾患で、一般的には妊娠、出産、幼児期に発達中の脳に損傷を受けることによって引き起こされます。この疾患はあらゆる年齢の人に影響を及ぼし、生活の質に大きな影響を与えます。世界市場の成長にはいくつかの要因が寄与しています。まず第一に、脳性麻痺の世界の有病率の増加が大きな促進要因となっています。最近の研究によると、脳性麻痺の罹患率は増加傾向にあり、効果的な治療法や療法の必要性が高まっています。また、診断技術や画像診断の向上といった医療技術の進歩により、脳性麻痺の早期発見・診断が容易になり、タイムリーな介入・治療が可能となっています。さらに、ヘルスケア専門家、介護者、一般市民の間で脳性麻痺に対する認識が高まり、適切な治療法に対する需要が高まっています。このため、脳性麻痺患者の症状を緩和し、全体的な幸福を向上させるために、薬物療法、手術、リハビリテーション療法、補助器具などの新しい治療法の開発に焦点を当てた研究開発活動が活発化しています。
世界の脳性麻痺治療市場の成長に影響を与える主な要因としては、脳性麻痺の有病率の増加、新しい脳性麻痺治療薬へのアクセスの増加とともにヘルスケア技術の進歩への注目が高まっていること、研究開発の熟練度が高まっていること、意識を高めるための政府の取り組み、薬への依存度が高まっていることなどが挙げられます。
脳性麻痺治療市場は、薬剤費の高騰別課題に直面すると予測されます。また、脳性麻痺治療市場に対する障壁としては、疲労感、憂鬱感、頭痛、無気力、見当識障害、めまいなどの薬剤副作用や、貧困国や後進国における理解不足などが挙げられます。
当レポートは、世界の脳性麻痺治療市場について調査し、市場の概要とともに、タイプ別、流通別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。
目次
エグゼクティブサマリー
親市場分析
市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 動向分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品分析
- マクロ経済指標
- トップ投資分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制状況
- ポーター分析
世界の脳性麻痺治療市場、タイプ別
- 市場概要
- 手術・投薬
世界の脳性麻痺治療市場、流通別
- 市場概要
- 病院薬局
- 小売薬局とオンライン薬局
世界の脳性麻痺治療市場、地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
競合情勢
- 主要企業プロファイル
- Medtronic PLC
- Abbott Laboratories
- Johnson & Johnson
- Boston Scientific Corporation
- Novartis AG
- Pfizer Inc.
- GlaxoSmithKline PLC
- Merck & Co., Inc.
- Sanofi SA
- Allergan PLC
- Teva Pharmaceutical Industries Ltd.
- AstraZeneca PLC
- Bayer AG
- Roche Holding AG
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Biogen Inc.
- Shire
- AbbVie Inc.
- Stryker Corporation
Global Cerebral Palsy Treatment Market size was valued at USD 3.11 billion in 2021 and is poised to grow from USD 3.21 billion in 2022 to USD 4.3 billion by 2030, growing at a CAGR of 3.3% in the forecast period (2023-2030).
The global cerebral palsy treatment market is a dynamic and rapidly growing sector in the healthcare industry. Cerebral palsy is a neurological disorder that affects muscle control, coordination, and movement, typically caused by damage to the developing brain during pregnancy, childbirth, or early childhood. This condition affects individuals of all ages and has a significant impact on their quality of life. Several factors contribute to the growth of the global market. First and foremost, the increasing prevalence of cerebral palsy worldwide is a major driving factor. According to recent studies, the incidence of cerebral palsy has been on the rise, necessitating the need for effective treatments and therapies. Additionally, advancements in medical technology, such as improved diagnostic techniques and imaging modalities, have facilitated early detection and diagnosis of cerebral palsy, enabling timely intervention and treatment. Moreover, growing awareness about cerebral palsy among healthcare professionals, caregivers, and the general public has fueled the demand for appropriate treatment options. This has led to increased research and development activities focused on developing novel therapeutic approaches, including medications, surgeries, rehabilitation therapies, and assistive devices, to alleviate the symptoms and improve the overall well-being of individuals with cerebral palsy.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cerebral Palsy Treatment Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cerebral Palsy Treatment Market Segmental Analysis
Global Cerebral Palsy Treatment Market is segmented by type, distribution, and region. Based on type, the market can be segmented into surgery and medication. Based on distribution, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Cerebral Palsy Treatment Market
Increasing the research activity and advancing healthcare technology
- The major factors influencing the growth of the global cerebral palsy treatment market include an increase in the prevalence of the condition, increased focus on healthcare technological advancements along with growing accessibility to newer cerebral palsy drugs, rising research and development proficiencies, government initiatives to raise awareness, and growing reliance on medications.
Restraints in the Global Cerebral Palsy Treatment Market
High cost associated with medications and their side-effects
- The cerebral palsy treatment market is anticipated to face challenges due to the high costs of drugs. In addition, barriers to the market for treating cerebral palsy include drug side effects such tiredness, melancholy, headaches, lethargy, disorientation, and dizziness as well as a lack of understanding in poor and backward economies.
Market Trends of the Global Cerebral Palsy Treatment Key
- The global cerebral palsy treatment market is witnessing several key trends. There is a growing demand for advanced therapeutics and treatment options, including stem cell therapy and robotic-assisted rehabilitation. Early intervention and multidisciplinary care are being emphasized to improve outcomes. Research and development activities are increasing, focusing on developing new medications and therapies. Patient-centric care and empowerment are gaining importance, leading to the development of patient support programs and online communities. Cost-effective healthcare solutions and reimbursement policies are being emphasized. Overall, these trends aim to improve outcomes and enhance the quality of life for individuals with cerebral palsy.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Cerebral Palsy Treatment Market by Type
- Market Overview
- Surgery and Medication
- Global Cerebral Palsy Treatment Market by Distribution
- Market Overview
- Hospital pharmacies
- Retail pharmacies and Online pharmacies
- Global Cerebral Palsy Treatment Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Allergan PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bristol-Myers Squibb Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biogen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shire (now part of Takeda Pharmaceutical Company Limited) (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
